These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 3884399)

  • 1. [Trials on bulla induction by antibodies from bullous pemphigoid patients in vivo and in vitro].
    Lohrisch I; Noack H; Haustein UF; Sparmann G; Koch J
    Dermatol Monatsschr; 1985; 171(2):106-12. PubMed ID: 3884399
    [No Abstract]   [Full Text] [Related]  

  • 2. [Transitory immune-complex nephritis in bullous pemphigoid].
    Lohrisch I; Achenbach H; Haustein UF; Herrmann K
    Dermatol Monatsschr; 1982 Jul; 168(7):477-82. PubMed ID: 6215269
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the autoimmune pathogenesis of bullous pemphigoid. Review of the literature and our results (author's transl)].
    Haustein UF; Lohrisch I; Herrmann K
    Dermatol Monatsschr; 1980 Sep; 166(9):585-98. PubMed ID: 7004925
    [No Abstract]   [Full Text] [Related]  

  • 4. Binding cells of bullous pemphigoid antibodies to basal cells.
    Krasny S; Beutner EH; Kumar V; Jablonska S; Chorzelski TP
    J Invest Dermatol; 1981 Aug; 77(2):251. PubMed ID: 7024427
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunologic phenomena in the skin of patients with pemphigoid in relation to the pathologic process].
    Torzecka JD; Lutowiecka-Wranicz A; Sysa-Jedrzejowska A; Waszczykowska E; Dziankowska-Bartkowiak B
    Przegl Dermatol; 1988; 75(4):266-71. PubMed ID: 3070636
    [No Abstract]   [Full Text] [Related]  

  • 6. Localized pemphigoid: a case report showing in situ deposition as well as presence in serum of IgG and IgA anti-basement membrane zone antibodies.
    Sugihara K; Dekio S; Tohgi K; Jidoi J
    J Dermatol; 1987 Feb; 14(1):73-6. PubMed ID: 3301954
    [No Abstract]   [Full Text] [Related]  

  • 7. An immunological study of patients with bullous pemphigoid.
    Hovmark A; Asbrink E
    Acta Derm Venereol; 1982; 62(3):201-4. PubMed ID: 6179358
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanisms of immunologic injury. Pemphigus and bullous pemphigoid.
    Anhalt GJ; Patel H; Diaz LA
    Arch Dermatol; 1983 Sep; 119(9):711-4. PubMed ID: 6351756
    [No Abstract]   [Full Text] [Related]  

  • 9. A child with antibodies targeting both linear IgA bullous dermatosis and bullous pemphigoid antigens.
    Darling TN; Cardenas AA; Beard JS; Sau P; Yee CL; Zone JJ; Yancey KB
    Arch Dermatol; 1995 Dec; 131(12):1438-42. PubMed ID: 7492135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal conditions of 1 M NaCl splitting technique to demonstrate basement membrane zone antigens in bullous pemphigoid, epidermolysis bullosa acquisita and linear IgA bullous dermatoses.
    Jenkins RE; Rodenas J; Bhogal BS; Black MM
    Dermatology; 1994; 189 Suppl 1():133-4. PubMed ID: 8049556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Papules with basement membrane zone antibodies preceding bullous pemphigoid.
    Lorette G; Fetissoff F
    Arch Dermatol; 1982 Nov; 118(11):878-9. PubMed ID: 6753763
    [No Abstract]   [Full Text] [Related]  

  • 12. Evolving concept of IgA linear dermatosis.
    Chorzelski T; Jablonska S
    Semin Dermatol; 1988 Sep; 7(3):225-32. PubMed ID: 3153448
    [No Abstract]   [Full Text] [Related]  

  • 13. Ultrastructural localization of in vitro binding sites of circulating anti-basement membrane zone antibodies in bullous pemphigoid.
    Yamasaki Y; Nishikawa T
    Acta Derm Venereol; 1983; 63(6):501-6. PubMed ID: 6198839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Psoriasis and bullous pemphigoid].
    Bork K
    Hautarzt; 1987 Jun; 38(6):348-51. PubMed ID: 3308771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum IgE levels in patients with bullous pemphigoid.
    Nieboer C
    Acta Derm Venereol; 1985; 65(3):273-4. PubMed ID: 2411092
    [No Abstract]   [Full Text] [Related]  

  • 16. Induction of leukocyte adherence at the basement membrane zone with subsequent activation of their metabolic pathway by pemphigoid antibodies and complement.
    Iwatsuki K; Tagami H; Yamada M
    Acta Derm Venereol; 1983; 63(4):290-5. PubMed ID: 6195859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Demonstration of pemphigoid antibodies].
    Kühn G; Jarzabek-Chorzelska M; Kolacinska-Strasz Z
    Dermatol Monatsschr; 1988; 174(2):99-102. PubMed ID: 3286306
    [No Abstract]   [Full Text] [Related]  

  • 18. Localized bullous pemphigoid with negative immunofluorescence.
    Silber JG; Brody N
    Cutis; 1981 Nov; 28(5):562, 565. PubMed ID: 7030649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of bullous pemphigoid and transitional cell carcinoma of the bladder. Demonstration of a circulating factor reactive with basement membrane zone of skin and of bladder carcinoma.
    Tanaka T; Ogino A; Ogura K; Nakagawa K
    Arch Dermatol; 1983 Aug; 119(8):704-5. PubMed ID: 6347090
    [No Abstract]   [Full Text] [Related]  

  • 20. [Induction of pemphigoid lesions in neonatal mice].
    Mitsuhashi Y; Takahashi M; Sawamura D; Yamatani S; Hashimoto I; Katabira Y
    Nihon Hifuka Gakkai Zasshi; 1985 May; 95(6):675-80. PubMed ID: 3897671
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.